LongevityFP Technologies

LongevityFP Technologies is a healthcare technology company dedicated to the commercialization of advanced epigenetic underwriting solutions. Founded by Jon R. Sabes, the company leverages a proprietary platform that combines DNA epigenetic data with machine learning to assess human health and longevity. In 2026, the firm entered into an exclusive strategic partnership and licensing agreement with FOXO Technologies to utilize its pioneering epigenetics intellectual property. The company's primary focus is modernizing the life insurance industry through non-invasive, data-driven health assessments. LongevityFP also maintains a long-term option to acquire majority ownership of FOXO Labs, Inc.